This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A New, Pink, Refractive, Microform Crystal

BERNARD APPEL, M.D.; LESLIE M. OHMART, M.Sc.; ROBERT F. STERNER, M.D.

AMA Arch Derm. 1956;73(4):318-324.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

ZINC OXIDE

Zinc oxide has been used as a dermatotherapeutic agent for a long time. Pliny the Elder mentioned the use of zinc oxide.¹ The standard texts of the latter half of the 19th century mention zinc oxide so casually and so consistently that we may assume it has been used in dermatological formulations for the past 100 years to about the same degree as we are using it today. In the course of a not too profound search for the pharmacology of zinc oxide, the absence of any extensive studies was both striking and unexpected. During a discussion of this subject, one of us (B. A.), who has been teaching and practicing dermatology for 30 years, was startled by the realization that he could not give a very profound pharmacological answer to the question, "Why do you prescribe zinc oxide?'' An unstudied answer to this ques . . . [Full Text PDF of this Article]

Author Affiliations
Lynn, Mass.; Boston; Rahway, N. J.

Footnotes
Recorded for publication July 28, 1955.

Read before the Section on Dermatology and Syphilology at the 104th Annual Meeting of the American Medical Association, Atlantic City, June 9, 1955.

Physician-in-Chief, Department of Dermatology, The Boston City Hospital, Chairman of the Department and Professor of Dermatology and Syphilology, School of Medicine, Tufts University (Dr. Appel); Professor of Pharmacy, Massachusetts College of Pharmacy (Mr. Ohmart); Medical Department Chemical Division, Merck & Co., Inc., (Dr. Sterner).

The product used (Neo-Zinc Oxide Hyperfine) was first supplied us by Dr. Max Tishler, Director of Process Research and Development Division, Chemical Division, Merck & Co., Inc. Through the coordination by Dr. A. B. Scott, Director of Product Development, various departments of the Chemical Division of Merck & Co., Inc., supplied materials, electron photomicrographs, and technical data, and performed bacteriostatic tests for this investigation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?